What is Array BioPharma?

Array BioPharma is a biopharmaceutical company that focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat cancer and other diseases. Founded in 1998 and headquartered in Boulder, Colorado, Array has developed several innovative therapies, including drugs for melanoma and colorectal cancer. The company is known for its expertise in chemistry and drug design, and it has collaborated with major pharmaceutical firms to advance its research. In 2019, Array BioPharma was acquired by Pfizer, further expanding its impact in oncology therapeutics.